{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:54:22Z","timestamp":1791053662317,"version":"4.1.0"},"reference-count":44,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,9,14]],"date-time":"2009-09-14T00:00:00Z","timestamp":1252886400000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:p>Passive immunotherapy of cancer (i.e., transfer of T cells or antibodies) can lead to some objective clinical responses, thus demonstrating that the immune system can reject tumors. However, passive immunotherapy is not expected to yield memory T cells that might control tumor outgrowth. Active immunotherapy with dendritic cell (DC) vaccines has the potential to induce tumor\u2010specific effector and memory T cells. Clinical trials testing first\u2010generation DC vaccines pulsed with tumor antigens provided a proof\u2010of\u2010principle that therapeutic immunity can be elicited. Newer generation DC vaccines are built on the increased knowledge of the DC system, including the existence of distinct DC subsets and their plasticity all leading to the generation of distinct types of immunity. Rather than the quantity of IFN\u2010\u03b3\u2010secreting CD8<jats:sup>+<\/jats:sup> T cells, we should aim at generating high\u2010quality, high\u2010avidity, polyfunctional effector CD8<jats:sup>+<\/jats:sup> T cells able to reject tumors and long\u2010lived memory CD8<jats:sup>+<\/jats:sup> T cells able to prevent relapse.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2009.05000.x","type":"journal-article","created":{"date-parts":[[2009,9,14]],"date-time":"2009-09-14T21:15:32Z","timestamp":1252962932000},"page":"88-98","source":"Crossref","is-referenced-by-count":42,"title":["Harnessing Dendritic Cells to Generate Cancer Vaccines"],"prefix":"10.1111","volume":"1174","author":[{"given":"Karolina","family":"Palucka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Banchereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,9,14]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra072739"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60404-9"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature06175"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20032220"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2007.00575.x"},{"key":"e_1_2_7_7_2","first-page":"6451","article-title":"Immune and clinical responses in patients with metastatic melanoma to CD34+ progenitor\u2010derived dendritic cell vaccine","volume":"61","author":"Banchereau J.","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20032118"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.cji.0000154249.74383.17"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.cji.0000211309.90621.8b"},{"key":"e_1_2_7_11_2","first-page":"1","article-title":"Long\u2010term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide\u2010pulsed CD34(+) progenitor\u2010derived dendritic cells","volume":"55","author":"Fay J.W.","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0398-328"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.11.1669"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.07.013"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.1.83"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1592"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636329"},{"key":"e_1_2_7_18_2","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.4049\/jimmunol.159.10.4772","article-title":"Induction of tolerance by IL\u201010\u2010treated dendritic cells","volume":"159","author":"Steinbrink K.","year":"1997","journal-title":"J. Immunol."},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni805"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2005.05.011"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1997"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050810"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1372"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00617.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1261"},{"key":"e_1_2_7_26_2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4049\/jimmunol.159.1.28","article-title":"IL\u201012\u2010deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells","volume":"159","author":"Kalinski P.","year":"1997","journal-title":"J. Immunol."},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3466"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.4.1975"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062387"},{"key":"e_1_2_7_30_2","first-page":"8643","article-title":"Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase\u2010related protein 2\u2010transduced dendritic cells enhance the interferon alpha\u2010induced, CD8(+) T\u2010cell\u2010dependent immune defense of B16 melanoma","volume":"61","author":"Steitz J.","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0710557105"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.155.4.1063"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.11.1637"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1076514"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0804-806"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062363"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.5.2523"},{"key":"e_1_2_7_38_2","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.4049\/jimmunol.162.4.2227","article-title":"Isolation of high avidity melanoma\u2010reactive CTL from heterogeneous populations using peptide\u2010MHC tetramers","volume":"162","author":"Yee C.","year":"1999","journal-title":"J. Immunol."},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1083"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-7-45"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021553"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070070"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.05.012"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082292"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1688"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2009.05000.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2009.05000.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T09:52:42Z","timestamp":1695635562000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2009.05000.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1749-6632.2009.05000.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05000.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}